KLRS

Kalaris Therapeutics

85 hedge funds and large institutions have $192M invested in Kalaris Therapeutics in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding

Funds holding:

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

34% less capital invested

Capital invested by funds: $294M → $192M (-$101M)

Holders
85
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$110K
Puts
$81K
Net Calls
Net Calls Change

Top Buyers

1 +$1.81M
2 +$766K
3 +$743K
4
Renaissance Technologies
Renaissance Technologies
New York
+$632K
5
Citadel Advisors
Citadel Advisors
Florida
+$399K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$36.1M
2
$28.6M
3
$23.6M
4
$15.1M
5
$14.5M
6
$14.2M
7
$9.79M
8
$5.87M
9
$5.58M
10
$5.03M
11
$4.94M
12
$4.51M
13
$3.91M
14
$2.36M
15
$2.12M
16
$1.67M
17
$1.56M
18
$1.16M
19
$1.11M
20
$833K
21
$831K
22
$576K
23
$561K
24
$422K
25
$407K